Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
BioNTech SE (/biːˈɒntɛk/ bee-ON-tek; or /baɪˈɒntɛk/ bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The analysis highlights History, Art, Technology and Companies as prominent areas in the source structure around BioNTech.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around BioNTech shows recurring relationship patterns in the source. For example, BioNTech → Africa, Asia, Australia, Austria, Berkeley Heights, Berlin, BioNTech's, Cambridge, China, England, Europe, Gaithersburg, Germany, GMP-certified, Halle, Idar-Oberstein, Istanbul, Kigali, London, Mainz Another extracted example is BioNTech → ADS, American Depository Shares, Bill, BNTX, BVCF Management, EIB, Europe, European Commission Investment Plan, European Investment Bank, Fidelity Management, In December, In July, In September, Invus, IPO, Jebsen Capital, Melinda Gates Foundation, Mirae Asset Financial Group, NASDAQ Global Select Market, October. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
company vaccine mrna-based covid-19 cancer mrna pfizer development research million 2020 vaccines manufacturing diseases germany 2026 us biontech's 2019 also
TTTA extracted 193 structured relationships around BioNTech. Examples in this analysis include BioNTech → Area served → Worldwide and BioNTech → Founded → 2008; 18 years ago (2008). The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| BioNTech | Area served | Worldwide | 1.00 | infobox |
| BioNTech | Founded | 2008; 18 years ago (2008) | 1.00 | infobox |
| BioNTech | Founders | Uğur Şahin | 1.00 | infobox |
| BioNTech | Founders | Özlem Türeci | 1.00 | infobox |
| BioNTech | Founders | Christoph Huber | 1.00 | infobox |
| BioNTech | Headquarters | Mainz, Germany | 1.00 | infobox |
| BioNTech | Industry | Biotechnology | 1.00 | infobox |
| BioNTech | ISIN | US09075V1026 | 1.00 | infobox |
| BioNTech | Key people | Uğur Şahin (CEO) | 1.00 | infobox |
| BioNTech | Key people | Annemarie Hanekamp (CCO) | 1.00 | infobox |
| BioNTech | Key people | Kylie Jimenez (CPO) | 1.00 | infobox |
| BioNTech | Key people | Sierk Pötting (COO) | 1.00 | infobox |
| BioNTech | Key people | James Ryan (CLO, CBO) | 1.00 | infobox |
| BioNTech | Key people | Özlem Türeci (CMO) | 1.00 | infobox |
| BioNTech | Key people | Ramón Zapata (CFO) | 1.00 | infobox |
| BioNTech | Net income | €−1.14 billion (2025) | 1.00 | infobox |
| BioNTech | Number of employees | 7,807 (2025) | 1.00 | infobox |
| BioNTech | Number of locations | 26 (2026) | 1.00 | infobox |
| BioNTech | Operating income | €−1.40 billion (2025) | 1.00 | infobox |
| BioNTech | Products | Pfizer-BioNTech COVID-19 vaccine, Immunotherapy and vaccine candidates | 1.00 | infobox |
| BioNTech | Revenue | €2.87 billion (2025) | 1.00 | infobox |
| BioNTech | Services | Immunotherapy | 1.00 | infobox |
| BioNTech | Total assets | €21.99 billion (2025) | 1.00 | infobox |
| BioNTech | Total equity | €19.22 billion (2025) | 1.00 | infobox |
| BioNTech | Traded as | Nasdaq: BNTX | 1.00 | infobox |
| BioNTech | Type | Public company | 1.00 | infobox |
| BioNTech | Website | biontech.com | 1.00 | infobox |
The concept neighborhoods around BioNTech bring nearby vocabulary together. In this analysis, examples include Vaccine, Cancer and Million. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For BioNTech, one of the stronger structural bridges in this analysis connects BioNTech with History. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around BioNTech to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Art, Technology & Companies, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — BioNTech · EN edition · Analysis: TopicsToTalkAbout
